277 related articles for article (PubMed ID: 9892398)
1. Antiretroviral therapy with protease inhibitors in human immunodeficiency virus type 1- and human herpesvirus 8-coinfected patients.
De Milito A; Catucci M; Venturi G; Romano L; Incandela L; Valensin PE; Zazzi M
J Med Virol; 1999 Feb; 57(2):140-4. PubMed ID: 9892398
[TBL] [Abstract][Full Text] [Related]
2. Acquired immunodeficiency syndrome-related Kaposi's sarcoma regression after highly active antiretroviral therapy: biologic correlates of clinical outcome.
Cattelan AM; Calabrò ML; Gasperini P; Aversa SM; Zanchetta M; Meneghetti F; De Rossi A; Chieco-Bianchi L
J Natl Cancer Inst Monogr; 2001; (28):44-9. PubMed ID: 11158206
[TBL] [Abstract][Full Text] [Related]
3. Viral load of human herpesvirus 8 in peripheral blood of human immunodeficiency virus-infected patients with Kaposi's sarcoma.
Tedeschi R; Enbom M; Bidoli E; Linde A; De Paoli P; Dillner J
J Clin Microbiol; 2001 Dec; 39(12):4269-73. PubMed ID: 11724831
[TBL] [Abstract][Full Text] [Related]
4. Relationship of human herpesvirus 8 peripheral blood virus load and Kaposi's sarcoma clinical stage.
Campbell TB; Borok M; Gwanzura L; MaWhinney S; White IE; Ndemera B; Gudza I; Fitzpatrick L; Schooley RT
AIDS; 2000 Sep; 14(14):2109-16. PubMed ID: 11061651
[TBL] [Abstract][Full Text] [Related]
5. Clinical and biological impact of antiretroviral therapy with protease inhibitors on HIV-related Kaposi's sarcoma.
Lebbé C; Blum L; Pellet C; Blanchard G; Vérola O; Morel P; Danne O; Calvo F
AIDS; 1998 May; 12(7):F45-9. PubMed ID: 9619797
[TBL] [Abstract][Full Text] [Related]
6. Detection of Kaposi's sarcoma-associated herpesvirus in peripheral blood cells in human immunodeficiency virus infection: association with Kaposi's sarcoma, CD4 cell count, and HIV RNA levels.
Min J; Katzenstein DA
AIDS Res Hum Retroviruses; 1999 Jan; 15(1):51-5. PubMed ID: 10024052
[TBL] [Abstract][Full Text] [Related]
7. Clearance of human herpesvirus type 8 viraemia in HIV-1-positive patients with Kaposi's sarcoma treated with liposomal doxorubicin. Caelyx/KS Spanish Study Group.
Núñez M; Machuca A; Soriano V; Podzamczer D; González-Lahoz J
AIDS; 2000 May; 14(8):913-9. PubMed ID: 10853972
[TBL] [Abstract][Full Text] [Related]
8. Human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus) infection in men receiving treatment for HIV-1 infection.
Campbell TB; Fitzpatrick L; MaWhinney S; Zhang X; Schooley RT
J Acquir Immune Defic Syndr; 1999 Dec; 22(4):333-40. PubMed ID: 10634194
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the human herpesvirus 8 DNA load in blood and Kaposi's sarcoma skin lesions from AIDS patients on highly active antiretroviral therapy.
Boivin G; Gaudreau A; Routy JP
AIDS; 2000 Sep; 14(13):1907-10. PubMed ID: 10997393
[TBL] [Abstract][Full Text] [Related]
10. Effect of human immunodeficiency virus-1 protease inhibitors on the clearance of human herpesvirus 8 from blood of human immunodeficiency virus-1-infected patients.
Leao JC; Kumar N; McLean KA; Porter SR; Scully CM; Swan AV; Teo CG
J Med Virol; 2000 Dec; 62(4):416-20. PubMed ID: 11074468
[TBL] [Abstract][Full Text] [Related]
11. Kaposi's sarcoma (KS)-associated herpesvirus-like DNA sequences in peripheral blood mononuclear cells: association with KS and persistence in patients receiving anti-herpesvirus drugs.
Humphrey RW; O'Brien TR; Newcomb FM; Nishihara H; Wyvill KM; Ramos GA; Saville MW; Goedert JJ; Straus SE; Yarchoan R
Blood; 1996 Jul; 88(1):297-301. PubMed ID: 8704186
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of plasma human herpesvirus 8 DNA as a marker of clinical outcomes during antiretroviral therapy for AIDS-related Kaposi sarcoma in Zimbabwe.
Borok M; Fiorillo S; Gudza I; Putnam B; Ndemera B; White IE; Gwanzura L; Schooley RT; Campbell TB
Clin Infect Dis; 2010 Aug; 51(3):342-9. PubMed ID: 20572760
[TBL] [Abstract][Full Text] [Related]
13. Clearance of HHV-8 from peripheral blood mononuclear cells with a protease inhibitor.
Rizzieri DA; Liu J; Traweek ST; Miralles GD
Lancet; 1997 Mar; 349(9054):775-6. PubMed ID: 9074582
[No Abstract] [Full Text] [Related]
14. The influence of highly active antiretroviral therapy on AIDS-associated Kaposi's sarcoma.
Dupin N; Rubin De Cervens V; Gorin I; Calvez V; Pessis E; Grandadam M; Rabian C; Viard JP; Huraux JM; Escande JP
Br J Dermatol; 1999 May; 140(5):875-81. PubMed ID: 10354025
[TBL] [Abstract][Full Text] [Related]
15. HHV-8 DNA replication correlates with the clinical status in AIDS-related Kaposi's sarcoma.
Broccolo F; Tassan Din C; Viganò MG; Rutigliano T; Esposito S; Lusso P; Tambussi G; Malnati MS
J Clin Virol; 2016 May; 78():47-52. PubMed ID: 26985593
[TBL] [Abstract][Full Text] [Related]
16. Response to liposomal doxorubicin and clinical outcome of HIV-1-infected patients with Kaposi's sarcoma receiving highly active antiretroviral therapy.
Núñez M; Saballs P; Valencia ME; Santos J; Ferrer E; Santos I; Berrocal A; Galindo MJ; Podzamczer D; Gonzlez-Lahoz J;
HIV Clin Trials; 2001; 2(5):429-37. PubMed ID: 11673818
[TBL] [Abstract][Full Text] [Related]
17. Human herpesvirus 8 DNA load in the leukocytes correlates with the platelet counts in HIV type 1-infected individuals.
Minami R; Yamamoto M; Takahama S; Ando H; Miyamura T; Suematsu E
AIDS Res Hum Retroviruses; 2009 Jan; 25(1):1-8. PubMed ID: 19182916
[TBL] [Abstract][Full Text] [Related]
18. Detection of the herpesvirus-like DNA sequences in matched specimens of semen and blood from patients with AIDS-related Kaposi's sarcoma by polymerase chain reaction in situ hybridization.
Huang YQ; Li JJ; Poiesz BJ; Kaplan MH; Friedman-Kien AE
Am J Pathol; 1997 Jan; 150(1):147-53. PubMed ID: 9006331
[TBL] [Abstract][Full Text] [Related]
19. Reduced human herpesvirus-8 oropharyngeal shedding associated with protease inhibitor-based antiretroviral therapy.
Gantt S; Cattamanchi A; Krantz E; Magaret A; Selke S; Kuntz SR; Huang ML; Corey L; Wald A; Casper C
J Clin Virol; 2014 Jun; 60(2):127-32. PubMed ID: 24698158
[TBL] [Abstract][Full Text] [Related]
20. Resolution of Kaposi's sarcoma associated with undetectable level of human herpesvirus 8 DNA in a patient with AIDS after protease inhibitor therapy.
Burdick AE; Carmichael C; Rady PL; Tyring SK; Badiavas E
J Am Acad Dermatol; 1997 Oct; 37(4):648-9. PubMed ID: 9344209
[No Abstract] [Full Text] [Related]
[Next] [New Search]
